Search results
Results From The WOW.Com Content Network
AWHONN also publishes multiple evidence-based nursing guidelines for use by nurses caring for women and newborns. These evidence-based guidelines cover topics like fetal heart rate monitoring , labor induction , neonatal skin care, [ 4 ] care of the late preterm infant, [ 5 ] breastfeeding , HPV counseling, neonatal hyperbilirubinemia , nursing ...
A nonstress test (NST) is a screening test used in pregnancy to assess fetal status by means of the fetal heart rate and its responsiveness. A cardiotocograph is used to monitor the fetal heart rate and presence or absence of uterine contractions. The test is typically termed "reactive" (also "reassuring") or "nonreactive" (also "nonreassuring ...
Modern-day CTG was developed and introduced in the 1950s and early 1960s by Edward Hon, Roberto Caldeyro-Barcia and Konrad Hammacher. The first commercial fetal monitor (Hewlett-Packard 8020A) was released in 1968. [1] CTG monitoring is widely used to assess fetal well-being by identifying babies at risk of hypoxia (lack of oxygen). [2]
During uterine contractions, fetal oxygenation is worsened. Late decelerations in fetal heart rate occurring during uterine contractions are associated with increased fetal death rate, growth retardation and neonatal depression. [1] [2] This test assesses fetal heart rate in response to uterine contractions via electronic fetal monitoring.
A biophysical profile (BPP) is a prenatal ultrasound evaluation of fetal well-being involving a scoring system, [1] with the score being termed Manning's score. [2] It is often done when a non-stress test (NST) is non reactive, or for other obstetrical indications.
Topics include assisted vaginal delivery, Doppler fetal monitoring, fetal dystocias, neonatal resuscitation, management premature labor, management of postpartum hemorrhage, along with forceps and vacuum-assisted delivery. Participants must pass a written test as well as a practical hands-on case management of a birth (mega-delivery ...
Maternal–fetal medicine began to emerge as a discipline in the 1960s. Advances in research and technology allowed physicians to diagnose and treat fetal complications in utero, whereas previously, obstetricians could only rely on heart rate monitoring and maternal reports of fetal movement.
The use of fetal scalp blood testing originated in Germany in 1961 and required 0.25 mL of blood drawn from the fetus. [1] As one of the first methods of monitoring fetal wellbeing during labor, there were many disadvantages including the need for at least 3 cm dilation of the mother and extreme precision from the physician performing the procedure. [9]